These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22095013)

  • 1. Long-term acid inhibition: benefits and harms.
    Tepeš B
    Dig Dis; 2011; 29(5):476-81. PubMed ID: 22095013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of proton pump-inhibiting drugs on mineral metabolism.
    Insogna KL
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy.
    Fashner J; Gitu AC
    FP Essent; 2013 Oct; 413():29-39. PubMed ID: 24124705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR; Targownik LE; Leslie WD
    Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors: potential adverse effects.
    Abraham NS
    Curr Opin Gastroenterol; 2012 Nov; 28(6):615-20. PubMed ID: 23010681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
    Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
    Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
    Heidelbaugh JJ; Metz DC; Yang YX
    Int J Clin Pract; 2012 Jun; 66(6):582-91. PubMed ID: 22607510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of proton pump inhibitor exposure.
    Yang YX; Metz DC
    Gastroenterology; 2010 Oct; 139(4):1115-27. PubMed ID: 20727892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications and safety of proton pump inhibitor drug use in patients with cancer.
    Triadafilopoulos G; Roorda AK; Akiyama J
    Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
    Koyyada A
    Therapie; 2021; 76(1):13-21. PubMed ID: 32718584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interaction between clopidogrel and proton pump inhibitors.
    Liu TJ; Jackevicius CA
    Pharmacotherapy; 2010 Mar; 30(3):275-89. PubMed ID: 20180611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor therapy and potential long-term harm.
    Corleto VD; Festa S; Di Giulio E; Annibale B
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):3-8. PubMed ID: 24310148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety concerns with proton pump inhibitors.
    Ali T; Roberts DN; Tierney WM
    Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction?
    Shmulevich E; Friger M; Gilutz H; Azab AN
    Can J Cardiovasc Nurs; 2011; 21(4):27-36. PubMed ID: 22165503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
    Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
    Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of the long-term use of proton pump inhibitors.
    Thomson AB; Sauve MD; Kassam N; Kamitakahara H
    World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.